Multiple studies have confirmed that the high expression of mmp-2 and mmp-9 is closely related to the clinical stage and metastasis of breast cancer, and the increase of these 2 proteases is more obvious in patients with early metastatic breast cancer.[14–16]. This evidence concerns the gene MMP2 and breast carcinoma.